607 results on '"Beaugrand M"'
Search Results
102. CA58 - Lésions histologiques hépatiques chez les adultes porteurs d’une mutation hétérozygote du gène mdr3 : prévalence élevée de la fibrose portale
103. CA13 - Diagnostic de la fibrose hépatique et de la cirrhose par mesure de l’élasticité hépatique chez les malades co-infectés VIH-VHC. étude prospective multicentrique
104. C023 - Évaluation non invasive de la fibrose chez les malades atteints d’hépatite B chronique avec le FibroScan®
105. CA8 - Polymorphismes SDF 1-3’A et CCR5D32 et risque de cirrhose, de carcinome hépatocellulaire et de mort chez les malades alcooliques ou infectés par le virus de l’hépatite C
106. C022 - Performances de la mesure de l’élasticité hépatique (MEH) pour le diagnostic de cirrhose au cours des maladies chroniques du foie (MCF) : étude multicentrique chez 1345 malades
107. CA7 - L’absence de stéatose est un facteur prédictif du décès chez les malades ayant une cirrhose virale C (HCV) de génotype non 3
108. CA14 - Intérêt de l’élastographie impulsionnelle pour l’évaluation de la fibrose hépatique au cours des maladies cholestatiques chroniques
109. CA3 - La mesure de l’élasticité du foie (MEF) améliore la prédiction du score de fibrose par le clinicien expérimenté chez les malades ayant une hépatite chronique C
110. CA21 - La présence d’au moins un alléle ala dans la séquence d’importation mitochondriale de la superoxyde dismutase a manganése est un facteur de risque de cirrhose alcoolique et de son évolution vers le carcinome hépatocellulaire et le décés
111. 54 Loss of maternal-specific methylation at the l'insuline growth factor 2 (IGF2) locus is a predictive factor for the occurrence of hepatocellular carcinoma (HCC) in hepatitis C virus (HCV) cirrhosis
112. 211 Effect of viral clearance on clinical outcome in patients with HCV-related cirrhosis or advanced fibrosis. A retrospective study in 138 patients
113. 459 Correlation between liver elasticity measured by transient elastography and liver fibrosis assessed by morphometry in patients with HCV chronic hepatitis
114. Intra-arterial treatments in patients with hepatocellular carcinoma
115. Adefovir dipivoxil (ADV) for the treatment of patients with chronic hepatitis B (CHB) failing lamivudine (LAM) therapy
116. Transient elastrography a new non invasive method for assessment of liver fibrosis: Results in patients with HCV chronic hepatitis
117. 576 Liver elasticity measurement by ultrasonic transient elastography: a new non-invasive method for assessment of liver fibrosis in chronic viral hepatitis
118. Portal pressure is not predictive of death in patients with Child-Pugh a HCV-cirrhosis
119. Screening and early treatment of hepatocellular carcinoma: results of a French survey
120. Small solitary hepatocellular carcinoma (HCC) in child a cirrhosis: prognostic factors of survival in 142 patients
121. CD8+ T lymphocyte infiltration of liver sinusoids could lead to nodular regenerative hyperplasia
122. Prevalence and predictive factors of large cell dysplasia (LCD) in chronic liver diseases
123. Autoimmune acute hepatitis: an underrecognized liver disease
124. Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer
125. Transjugular renal biopsy in the treatment of patients with cirrhosis and renal abnormalities
126. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis
127. Absence of anti-LKM-1 antibody in hepatitis C viral infection in the United States of America
128. HLA antigens in patients with chronic hepatitis C
129. HCV-associated liver cancer without cirrhosis
130. Fièvre prolongée et péliose hépatique révélant une maladie de Takayasu
131. Hépatite C et facteurs rhumatoïdes
132. Latent autoimmune thyroid disease in patients with chronic HCV hepatitis
133. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease
134. Latent autoimmune thyroid disease in patients with chronic HCV hepatitis
135. Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan®: validation in chronic hepatitis C.
136. Relationships between fibrosis amounts assessed by morphometry and liver stiffness measurements in chronic hepatitis or steatohepatitis.
137. Liver stiffness measurement in patients with cirrhosis and hepatocellular carcinoma: a case-control study.
138. Role of type IV collagen (CIV) in the pathogenesis of portal hypertension in patients with alcoholic cirrhosis
139. Liver injuries in diabetes mellitus(D): A prospective study
140. Chemoattractant and opsonic activity in ascitic fluid
141. Very high prevalence of sjogren syndrome in patients with HCV chronic hepatitis and cirrhosis
142. Use of adult human hepatocytes in primary culture for the study of clometacin-induced immunoallergic hepatitis
143. Large (>or=5.0-cm) HCCs: multipolar RF ablation with three internally cooled bipolar electrodes--initial experience in 26 patients.
144. Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study.
145. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis
146. Radioimmunoassay of type I collagen that mainly detects degradation products in serum: application to patients with liver diseases
147. The role of HCV in the pathogenesis of alcoholic cirrhosis: A histopathological study
148. Treatment of severe alcoholic hepatitis by infusion of insulin and glucagon. A multicentre sequential trial
149. Factor predictive of a response to interferrcn cherapy in NANB chronic active hepatitis
150. Elevation of CA 125 in patients with benign and malignant ascites.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.